Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)
Status:
Completed
Trial end date:
2011-04-08
Target enrollment:
Participant gender:
Summary
This is a multicenter study to test the hypothesis that telcagepant is superior to placebo in
preventing perimenstrual migraines as measured by mean monthly headaches during the entire
treatment period. This study will also evaluate the safety and tolerability of telcagepant
for female migraine participants.